New Milrinone Therapy Findings from Icahn School of Medicine at Mount Sinai Described (Novel Inhaled Pulmonary Vasodilators In Adult Cardiac Surgery: a Scoping Review).

A scoping review conducted by researchers at the Icahn School of Medicine at Mount Sinai explored the use of novel inhaled vasodilators, milrinone and levosimendan, as alternatives to conventional inhaled therapies for pulmonary hypertension (PH) in cardiac surgery. The review included 17 studies with a total of 969 patients and found that milrinone and levosimendan showed potential benefits such as ease of weaning from cardiopulmonary bypass and reduction in ventricular dysfunction. However, the review also noted that high-quality data are limited and more consistent outcome measures are needed to validate the effectiveness of these agents. The study was registered with the Open Science Framework. [Extracted from the article]

Copyright of Clinical Trials Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)